Biotech: Pressemitteilungen - Kategorie - Seite 97

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Abattis Names Jaouad Fichtali as Chief Technology Officer

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/17/14 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company f ...

Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV

OSLO, NORWAY: OSLO, NORWAY -- (Marketwired) -- 11/17/14 -- Bionor Pharma ASA (OSLO: BIONOR)Treatment with Vacc-4x + Revlimid (lenalidomide) was safe and well toleratedIncrease in CD4 count in both treatment groups ...

Threshold Pharmaceuticals Announces Phase 1/2 Interim Data Signaling Activity of TH-302 Plus Bevacizumab (Avastin(R)) in Patients With Glioblastoma

SOUTH SAN FRANCISCO, CA: 64% of Patients Achieved Stable Disease or Tumor Shrinkage on Combination Therapy Following Progression on Single-Agent Bevacizumab; U.S. FDA Set to Fund Phase 2 Investigator-Sponsored Trial ...

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2014

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 11/14/14 -- Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE: IMV), a clinical stage vaccine company, today released its financ ...

MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update

CEDAR KNOLLS, NJ: Third Quarter Marked by Positive, Statistically Significant Clinical Safety and Efficacy Data for Fortetropin(TM) Fueling Development of MYOS-Branded Proprietary Product Line; Company Plans to Impleme ...

Ceapro Inc. Reports Third Quarter 2014 Financial Results

EDMONTON, ALBERTA: - Company delivers strongest quarterly financial performance in its history - - Further increased revenue generation and market expansion expected in 2015 - ...

Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholders

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/14/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, t ...

ProMetic Reports its Third Quarter 2014 Highlights and Financial Results

LAVAL, QUEBEC: - 2014 year-to-date product sales $7.3 million compared to $6.8 million in 2013 - H2 2014 revenue guidance range of $15 million to $20 million reiterated - Plasminogen and PBI-4050 cleared by regulato ...

Precision Medical Products Inc. (PMP) Hires Greg Haas as New Director of Engineering

DENVER, PA: DENVER, PA -- (Marketwired) -- 11/13/14 -- (PMP) has hired Greg Haas as new Director of Engineering. Greg Haas, Director of Engineering, will have the responsibility for all engineering development ...

Ceapro Engages Jenene Thomas Communications, LLC as Strategic Investor Relations and Corporate Communications Advisor

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 11/13/14 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...

Vanderbilt University Study Demonstrates ProMetic's PBI-4050 Ability to Protect Against Diabetic Nephropathy in Type II Diabetes

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 11/13/14 -- In a recognized gold-standard preclinical model, PBI-4050 was shown to significantly:ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMet ...

Titan Pharmaceuticals Announces Third Quarter 2014 Financial Results

SOUTH SAN FRANCISCO, CA: Titan Management Team to Host Conference Call Nov. 14 at 11 a.m. EST ...

Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/13/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, t ...

Corbus Pharmaceuticals Reports 2014 Third Quarter Results and Business Update

NORWOOD, MA: NORWOOD, MA -- (Marketwired) -- 11/13/14 -- (OTCQB: CRBP) (the "Company"), an emerging growth drug development company focused on the development and commercialization of its lead product ...

UPDATE - Avita Medical Provides NICE Guidance Recommendation Update

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 11/12/14 -- Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and ...

Theravance Biopharma to Present at the Stifel Healthcare Conference on November 18th

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/12/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. opera ...

ImmuCell Announces Financial Results for Third Quarter of 2014

PORTLAND, ME: Sales for Third Quarter and Nine Months Increase 43% and 21%, Respectively ...

Avita Medical Provides NICE Guidance Recommendation Update

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 11/12/14 -- Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and ...

ViroCyt Wins Colorado BioScience Association's "Rising Star" Award

BOULDER, CO: BOULDER, CO -- (Marketwired) -- 11/12/14 -- , the leader in rapid virus quantification, announced today that it has received the "Rising Star" award from the Colorado Bioscience Association ...


Seite 97 von 255:  « ..  96 97 98  99  100  101  102  103  104  105  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z